Intense FDG uptake in a benign Hurthle cell adenoma

Clinical Nuclear Medicine

Volumn 29, Issue 10, 2004, Pages 664-666

  Rohren, Eric M ^a,b  

^a MAYO CLINIC   (United States)

^b Molecular Imaging of Bradenton   (United States)

Author keywords

TO COME

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

AGED; ARTICLE; CASE REPORT; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; DRUG UPTAKE; HUMAN; LUNG NODULE; MALE; ONCOCYTOMA; POSITRON EMISSION TOMOGRAPHY; SUBTOTAL THYROIDECTOMY; THYROID CARCINOMA; THYROID GLAND; THYROID NODULE;

ADENOMA, OXYPHILIC; AGED; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; RADIOPHARMACEUTICALS; SUBTRACTION TECHNIQUE; THYROID GLAND; THYROID NEOPLASMS;

EID: 13644264933     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-200410000-00021     Document Type: Article

References (8)

1. Ramos CD, Chisin R, Yeung HW, et al. Incidental focal thyroid uptake on FDG positron emission tomographic scans may represent a second primary tumor. Clin Nucl Med. 2001;26:193.
2. Van den Bruel A, Maes A, DePotter T, et al. Clinical relevance of thyroid fluorodeoxyglucose-whole body positron emission tomography incidentaloma. J Clin Endocrinol Metab. 2002;87:1517.
3. Hooft L, Hoekstra OS, Deville W, et al. Diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography in the follow-up of papillary or follicular thyroid cancer. J Clin Endocrinol Metab. 2001;86: 3779.
4. Diehl M, Risse JH, Brandt-Mainz K, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: results of a multicentre study. Eur J Nucl Med. 2001;28:1671.
5. Lowe VJ, Mullan BP, Hay ID, et al. 18F-FDG PET of patients with Hurthle cell carcinoma. J Nucl Med. 2003;44:1402.
6. Teneri F, Tekin E, Salmin B, et al. Hurthle cell neoplasms of the thyroid: predicting malignant potential. Endocr Reg. 2000;34:19.
7. Nguyen GK, Husain M, Akin MR. Cytodiagnosis of benign and malignant Hurthle cell lesions of the thyroid by fine-needle aspiration biopsy. Diagn Cytopathol. 1999;20:261.
8. Renshaw AA. Hurthle cell carcinoma is a better gold standard than Hurthle cell neoplasm for fine-needle aspiration of the thyroid: defining more consistent and specific cytologic criteria. Cancer. 2002;96:261.